What is Blood Sugar Strips Market?
A blood sugar test strip is a little disposable plastic strip and is a vital element of blood sugar meters that monitors and controls diabetes. These strips are impregnated with glucose oxidase, which reacts with glucose present within the blood then indicates the aldohexose level within the blood. The convenience offered by self-blood aldohexose testing over ancient ways is one of the most important drivers of the blood sugar test strip market. Self-testing permits diabetic and pre-diabetic individuals to keep a track of their blood sugar levels often while not visiting a clinic or diagnostic laboratory. A diabetic patient is predicted to check his sugar a minimum of 2-3 times daily, self-testing permits the patient to perform his test regularly at his home. The rising diabetic population is another major driver of the market. Diabetes is one of the most important issues for state bodies across the world. The number of diabetic populations across the globe is rising continuously.
The market study is being classified by Type (Use and Throw and Build-in Indicator), by Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Pre-Diabetes and Others) and major geographies with country level break-up.
Abbott (United States), Roche (Switzerland), ARKRAY, Inc. (Japan), Ascensia Diabetes Care (United States), LifeScan IP Holdings, LLC (United States), AgaMatrix (Germany), Johnson & Johnson (United States), Bionime Corporation (Taiwan) and ACON Laboratories, Inc. (United States) are some of the key players profiled in the study. Additionally, the Vendors which are also part of the research are Trividia Health, Inc. (United States) and Rossmax International Ltd. (Taiwan).
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Vendors will contribute to the maximum growth of Global Blood Sugar Strips market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Blood Sugar Strips market by Type, Application and Region.
On the basis of geography, the market of Blood Sugar Strips has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Increasing Demand from The Type-2 Diabetic Patients
- A Rise in Healthcare Expenditure
Market Trend
- Increase in The Prevalence of Diabetes in The Younger Population
- Increasing Awareness Propelled the Market
Restraints
Opportunities
- Increasing Government Initiatives to Increase the Use of The Strips
Challenges
- Lack of Skilled Professionals
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Manufacturers of Blood Sugar Strips, Suppliers and Distributors of Blood Sugar Strips, Venture Capitalists and Private Equity Firms and End-Use Industry